AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

FISHER & PAYKEL HEALTHCARE C

30.590

-0.770-2.46%

Volume:354.26K

Turnover:11.07M

Market Cap:17.93B

PE:107.78

High:31.200

Open:30.890

Low:30.460

Close:31.360

Loading ...

Overview Company News Filings

Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) institutional investors lost 8.5% last week but have benefitted from longer-term gains

Simply Wall St.

Why Block, Canyon, Fisher & Paykel Healthcare, and Mesoblast shares are falling today

ResMed's half-year FY25 results: solid growth & expanding opportunities

ASX Market Close: Trump tariff fears induce broad index boodbath | January 3, 2025

The Market Herald

New Zealand Shares Fall as Tariff War Jolts Global Markets

MT Newswires Live

Why Fisher & Paykel Healthcare, Magellan, Resolute Mining, and Westgold shares are sinking today

NZX Midday Sector Update: Industrial Services Soar, Health Tech Struggles

MT Newswires Live

Fisher & Paykel Healthcare Warns Company Costs Likely to Increase in Fiscal Year 2026 on the Impact of New US Tariffs

MT Newswires Live

Down 4%, is the ResMed share price in the buy zone?

Guess which ASX 100 share is sinking 8% because of Trump's tariffs

Fisher & Paykel point to raised costs in FY26 on back of Trump tariffs

The Market Herald

These ASX shares could rise 20% to 45%

5 ASX stocks to own as the market keeps rallying

Here's how the ASX 200 market sectors stacked up last week

Which ASX 200 large-cap shares outperformed their peers in 2024?

Healthy gains: 5 best ASX 200 healthcare shares of 2024

Here are the top 10 ASX 200 shares today

The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence

Simply Wall St.

4 key megatrends and a handful of ASX stock ideas to play them

Fisher & Paykel Healthcare Corp Ltd (FSPKF) (H1 2025) Earnings Call Highlights: Strong ...

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FPH.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FPH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FPH.AU\",,,,,undefined,":{"symbol":"FPH.AU","market":"AU","secType":"STK","nameCN":"FISHER & PAYKEL HEALTHCARE C","latestPrice":30.59,"timestamp":1745302320000,"preClose":31.36,"halted":0,"volume":354261,"delay":0,"nameEN":"FISHER & PAYKEL HEALTHCARE C","floatShares":583930680,"shares":586256654,"eps":0.283811644211186,"marketStatus":"Not Yet Opened","change":-0.77,"latestTime":"04-22 16:12:00 AEST","open":30.89,"high":31.2,"low":30.46,"amount":11067458,"amplitude":0.023597,"askPrice":31.33,"askSize":222,"bidPrice":30.33,"bidSize":329,"shortable":3,"etf":0,"ttmEps":0.283811644211186,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":31.36,"dividendRate":0.01288,"openAndCloseTimeList":[[1745280000000,1745301600000]],"volumeRatio":0.7941871565412928,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FPH.AU\",,,,,undefined,":{"symbol":"FPH.AU","floatShares":583930680,"roa":"10.85%","roe":"9.70%","lyrEps":0.213638,"volumeRatio":0.7941871565412928,"shares":586256654,"dividePrice":0.393812,"high":31.2,"amplitude":0.023597,"preClose":31.36,"low":30.46,"week52Low":24.023,"pbRate":"9.91","psRate":"10.12","week52High":35.745,"institutionHeld":0,"latestPrice":30.59,"committee":0.194192,"eps":0.283811644211186,"divideRate":0.01288,"volume":354261,"delay":0,"ttmEps":0.283811644211186,"open":30.89,"prevYearClose":34.95,"prevWeekClose":31.36,"prevMonthClose":30.25,"prevQuarterClose":30.25,"fiveDayClose":31.17,"twentyDayClose":29.72,"sixtyDayClose":35.24},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FPH.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2509786457","title":"Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) institutional investors lost 8.5% last week but have benefitted from longer-term gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2509786457","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509786457?lang=en_us&edition=fundamental","pubTime":"2025-02-07 03:42","pubTimestamp":1738870963,"startTime":"0","endTime":"0","summary":"Significantly high institutional ownership implies Fisher & Paykel Healthcare's stock price is sensitive to their trading actions. 46% of the business is held by the top 25 shareholders. If you want to know who really controls Fisher & Paykel Healthcare Corporation Limited , then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are institutions with 50% ownership. Put another way, the group faces the maximum upside potential .No shareholder likes losing money on their investments, especially institutional investors who saw their holdings drop 8.5% in value last week. However, the 43% one-year return to shareholders may have helped lessen their pain. But they would probably be wary of future losses.In the chart below, we zoom in on the different ownership groups of Fisher & Paykel Healthcare.View our latest analysis for Fisher & Paykel Healthcare. What Does The Institutional Ownership Tell Us About Fisher & Paykel Healthcare?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fisher-paykel-healthcare-corporation-limiteds-194243593.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7501","BK4193","FPH.AU","HCSG","FPH","BK7007","BK4137"],"gpt_icon":0},{"id":"2509244514","title":"Why Block, Canyon, Fisher & Paykel Healthcare, and Mesoblast shares are falling today","url":"https://stock-news.laohu8.com/highlight/detail?id=2509244514","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509244514?lang=en_us&edition=fundamental","pubTime":"2025-02-05 10:02","pubTimestamp":1738720974,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index (ASX: XJO) is on form and having a good session on Wednesday. In afternoon trade, the benchmark index is up 0.65% to 8,429 points. Four ASX shares that have failed to follow the m","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/05/why-block-canyon-fisher-paykel-healthcare-and-mesoblast-shares-are-falling-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7508","BK4137","BK4139","BK7067","BK7007","BK7501","FPH.AU","MSB.AU","XYZ.AU","BK7158","HCSG","MESO","XJO.AU","CAY.AU","BK7104"],"gpt_icon":0},{"id":"2508483938","title":"ResMed's half-year FY25 results: solid growth & expanding opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2508483938","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508483938?lang=en_us&edition=fundamental","pubTime":"2025-02-04 12:43","pubTimestamp":1738644202,"startTime":"0","endTime":"0","summary":"ResMed’s  half-year FY25 results reflect a company that is not only thriving in its core business but is also strategically positioned to capitalise on future growth opportunities.The company is currently at the forefront of respiratory healthcare innovation with a market capitalisation of $59 billion at $39 per share. The share price, which has risen 33 per cent over the past year, materially outperformed the ASX 100’s 9.9 per cent gain over the same period, indicating growing investor confidence in the firm’s trajectory.ResMed delivered impressive growth across key metrics for the first half of the 2025 financial year, underscoring sound fundamentals and operational performance.While ResMed recorded US$4.69 billion in sales for FY24, up from US$4.22 billion in FY23, the company is forecast to achieve US$5.25 billion in FY25.ResMed’s improving margins and steady growth underpin its valuation. Using a 12-year average price-to-earnings ratio  of 30 times FY24 EPS, the company’s valuatio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/resmed-s-half-year-fy25-results-solid-growth-expanding-opportunities","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/resmed-s-half-year-fy25-results-solid-growth-expanding-opportunities","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK4585","BK7104","BK4504","BK7096","LU2008162690.USD","BK4588","BK7501","LU2177674079.SGD","PER","RMD","RMD.AU","TAM.AU","FPH.AU","PER.AU","BK7007","BK4567","BK4548","BK4082"],"gpt_icon":0},{"id":"2508195996","title":"ASX Market Close: Trump tariff fears induce broad index boodbath | January 3, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2508195996","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508195996?lang=en_us&edition=fundamental","pubTime":"2025-02-03 13:55","pubTimestamp":1738562100,"startTime":"0","endTime":"0","summary":"The ASX200 closed down 1.8% at 8,379 points.United States tariffs on imports from China and fears of a global trade war weighed heavily on Aussie stocks today. The Aussie dollar hit a four-year low, dropping below 61 cents.Market darling Commonwealth Bank  shed 2% in early trade before paring losses, and big miner BHP  closed 1.8% lower.Health Care was the worst performing sector in a sea of red, down 2.25%, followed by Discretionary, down 2%, and Materials and Financials, both down around 1.9%.Hansen Technologies  closed up 2.2% after a trading update reaffirmed its revenue guidance of $398 million to $405 million and underlying EBITDA of $92 million to $101 million.Catalyst Metals  closed up 0.9% after it released an exploration update. The company says it has 10 rigs on site at the Plutonic Belt, drilling 320,000 metres at a cost of $40 million over the next 12 months.Lynas Rare Earths  closed up 3.6%, extending last weeks gains. Investors have been piling into the stock on news Gin","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-trump-tariff-fears-induces-broad-index-boodbath-january-3-2025-2025-02-03/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["CBA.AU","NVA.AU","CTT.AU","BK7104","BK7511","BK7049","CYL.AU","LYC.AU","HSN.AU","BHP.AU","BK7503","BK7007","BK7016","BK7507","BK7095","BK7021","BK7501","FPH.AU","BK7135"],"gpt_icon":0},{"id":"2508419167","title":"New Zealand Shares Fall as Tariff War Jolts Global Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2508419167","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508419167?lang=en_us&edition=fundamental","pubTime":"2025-02-03 12:56","pubTimestamp":1738558586,"startTime":"0","endTime":"0","summary":"New Zealand shares tumbled Monday as did most equities in Asia as US tariffs on Canadian, Mexican, and Chinese goods started to kick in and triggered the start of a trade war among the world's largest","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"682ba10a66e9d2c9a78c2886dc906ed7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NZ20C.NZ","BK7501","T10G.NZ","NZ50G.NZ","FPH.AU","BK7007"],"gpt_icon":0},{"id":"2508296166","title":"Why Fisher & Paykel Healthcare, Magellan, Resolute Mining, and Westgold shares are sinking today","url":"https://stock-news.laohu8.com/highlight/detail?id=2508296166","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508296166?lang=en_us&edition=fundamental","pubTime":"2025-02-03 10:08","pubTimestamp":1738548495,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200 Index(ASX: XJO) is having a very poor start to the week. In afternoon trade, the benchmark index is down 1.7% to 8,388.5 points. Four ASX shares that are falling more than most today a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/03/why-fisher-paykel-healthcare-magellan-resolute-mining-and-westgold-shares-are-sinking-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["MFG.AU","BK7501","WGX.AU","BK7104","FPH.AU","XJO.AU","HCSG","BK7062","BK7007","BK7506","BK4137","RSG.AU"],"gpt_icon":0},{"id":"2508415707","title":"NZX Midday Sector Update: Industrial Services Soar, Health Tech Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2508415707","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508415707?lang=en_us&edition=fundamental","pubTime":"2025-02-03 08:49","pubTimestamp":1738543752,"startTime":"0","endTime":"0","summary":"Industrial Services stocks gained the highest on the New Zealand exchange, rising 0.9% at midday Monday. The benchmark NZX index reached a new intra-day high.Ventia Services Group  rose almost 1% on its second consecutive session of gains.On the other hand, the health technology plunged over 4%.Fisher & Paykel Healthcare  dropped nearly 5% as it warned investors of company costs likely increasing in fiscal 2026 due to new US tariffs on Mexico as most of its US volumes are supplied through its Mexican manufacturing units.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NZ20C.NZ","BK7501","T10G.NZ","NZ50G.NZ","BK7055","FPH.AU","VNT.AU","BK7007"],"gpt_icon":0},{"id":"2508154065","title":"Fisher & Paykel Healthcare Warns Company Costs Likely to Increase in Fiscal Year 2026 on the Impact of New US Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2508154065","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508154065?lang=en_us&edition=fundamental","pubTime":"2025-02-03 07:57","pubTimestamp":1738540634,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare  said its costs are likely to increase in fiscal 2026 due to new US tariffs, according to a filing with Australia and New Zealand bourses.The new tariffs may add two to three years to the expectation of reaching a gross margin target of 65%, the filing said.The company currently manufactures about 45% of its products in Mexico and about 43% of its revenue came from the US in the fiscal first half ended Sept. 30, 2024, as about 60% of US volumes are supplied from the company's Mexico manufacturing facilities, the filing added.The US government recently said that a 25% tariff will be imposed on imports from Mexico and Canada, while a 10% tariff will be imposed on Chinese imports.The company will provide an update on the outlook for the fiscal year 2026 and an updated estimate of the timeframe to return to the gross margin target, in its earnings report for the fiscal year ending March scheduled for release at the end of May, per the filing.The company does not ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCSG","BK7007","BK7501","BK4137","FPH.AU"],"gpt_icon":0},{"id":"2508815231","title":"Down 4%, is the ResMed share price in the buy zone?","url":"https://stock-news.laohu8.com/highlight/detail?id=2508815231","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508815231?lang=en_us&edition=fundamental","pubTime":"2025-02-03 07:25","pubTimestamp":1738538758,"startTime":"0","endTime":"0","summary":"The ResMed Inc  share price is under pressure on Monday. In morning trade, the sleep disorder treatment company's shares are over 4% to $38.35. Why is the ResMed share price falling?Investors have been selling the company's shares this morning after its NYSE-listed shares tumbled on Wall Street on Friday night. While most analysts were very impressed with ResMed's performance in the second quarter, it seems that some investors saw something they didn't like. This could possibly be a slight softening of organic growth during the quarter. However, the decline seems excessive for this. And although rival Fisher & Paykel Healthcare Corporation Ltd  expects to be negatively impacted by trade tariffs, which explains its sizeable decline today, this isn't expected to be the case for ResMed. It believes that Donald Trump's action could be a boost to sales. Is this decline a buying opportunity?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/03/down-4-is-the-resmed-share-price-in-the-buy-zone/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4567","BK4585","LU2177674079.SGD","FPH.AU","BK7501","BK7007","BK4082","RMD.AU","BK4548","BK4504","RMD","BK4588","LU2008162690.USD"],"gpt_icon":0},{"id":"2508152315","title":"Guess which ASX 100 share is sinking 8% because of Trump's tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2508152315","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508152315?lang=en_us&edition=fundamental","pubTime":"2025-02-03 07:23","pubTimestamp":1738538615,"startTime":"0","endTime":"0","summary":"While the ASX 100 share doesn't currently anticipate a material impact from the announced tariffs on its net profit after tax in FY 2025, it believes its costs will increase in FY 2026 and weigh on its margins. Nevertheless, Fisher & Paykel Healthcare continues to expect to eventually reach its gross margin target of 65% through its long-standing continuous improvement activities across the entire business, coupled with efficient growth into existing infrastructure. The only problem is that the US tariffs may have added two to three years to that expectation. The ASX 100 share's managing director and CEO, Lewis Gradon, said:  The company takes a long-term view and will be working with global suppliers and US customers to provide solutions to best mitigate the impact of the tariffs on all parties. Fundamentally, our products and therapies are designed to improve care and outcomes for patients and to reduce the overall costs of providing healthcare. Across the business we are continuing ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/03/guess-which-asx-100-share-is-sinking-8-because-of-trumps-tariffs/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["FPH.AU","BK7501","BK7007"],"gpt_icon":0},{"id":"2508630196","title":"Fisher & Paykel point to raised costs in FY26 on back of Trump tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2508630196","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508630196?lang=en_us&edition=fundamental","pubTime":"2025-02-03 07:20","pubTimestamp":1738538400,"startTime":"0","endTime":"0","summary":"Fisher and Paykel  expects Donald Trump’s tariffs against Mexico to raise its costs in FY26, with a full outlook report to be calculated.Around half of FPH’s overall manufacturing takes place in Mexico, while the other half runs in New Zealand; and 43% of 1HFY25 revenues came from sales in the U.S.In the meantime, the company doesn’t expect a net profit decline for FY25, but highlighted in FY2026 “the company’s costs would likely increase… acknowledging the economic environment… may be fluid over this period.”“The company is currently working through the complexities associated with the imposition of the tariffs and will provide an update on outlook for the 2026 financial year as well as an updated estimate of the timeframe to return to the gross margin target, at its full-year results at the end of May.”The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a ce","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/fisher-paykel-point-to-raised-costs-in-fy26-on-back-of-trump-tariffs-2025-02-03/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7007","BK7501","FPH.AU"],"gpt_icon":0},{"id":"2505709987","title":"These ASX shares could rise 20% to 45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505709987","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505709987?lang=en_us&edition=fundamental","pubTime":"2025-01-23 05:04","pubTimestamp":1737579887,"startTime":"0","endTime":"0","summary":"Are you on the lookout for some big returns?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/23/these-asx-shares-could-rise-20-to-45/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7005","BK7162","FPH.AU","BK7083","BOE.AU","BK7501","HMC.AU","BK7062","BK7007","BK7104","TAM.AU"],"gpt_icon":0},{"id":"2503399442","title":"5 ASX stocks to own as the market keeps rallying","url":"https://stock-news.laohu8.com/highlight/detail?id=2503399442","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503399442?lang=en_us&edition=fundamental","pubTime":"2025-01-13 04:00","pubTimestamp":1736712015,"startTime":"0","endTime":"0","summary":"remains constructive. Recession fears have now receded, corporate earnings are forecast to grow, interest rates are set to moderate, and the narrow rally we saw in 2024 is set to broaden in 2025.In the first phase of a rate-cutting cycle, revenues begin to recover on reduced cost bases, which combined deliver expanded operating margins and profitability.We expect 2025 to be a good year for equity investors.  We continue to see value in several sectors,Here are five stocks that are well-positioned to outperform in 2025:. Importantly, the company has also secured funding for the product's use in the US via Transitional Pass Through  reimbursement. As a result,Cyclopharm expects the size of the US nuclear medicine PE market to double from US$90M to US$180M within the next 3-5 years.As a result, we expect strong earnings growth and improving profitability to drive share price outperformance over the long term. A strong 1H FY25 recently de","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/5-asx-stocks-to-own-as-the-market-keeps-rallying","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/5-asx-stocks-to-own-as-the-market-keeps-rallying","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["XJO.AU","XAO.AU","SKS.AU","BK7093","XKO.AU","BK7501","ZIP","ROIC","BK7007","EHL.AU","CYC.AU","BK4077","BK7023","ZIP.AU","BK4231","BK4080","FPH.AU","BK4539","BK7031"],"gpt_icon":0},{"id":"2502878743","title":"Here's how the ASX 200 market sectors stacked up last week","url":"https://stock-news.laohu8.com/highlight/detail?id=2502878743","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502878743?lang=en_us&edition=fundamental","pubTime":"2025-01-12 05:00","pubTimestamp":1736629200,"startTime":"0","endTime":"0","summary":"ASX200 healthcareshares led themarket sectorswith a 1.15% increase over the five trading days. The S&P/ASX 200 Index(ASX: XJO) gained 0.53% over the week to finish at 8,294.1 points on Friday. Seven o","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/12/heres-how-the-asx-200-market-sectors-stacked-up-last-week-22/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7124","BK7501","RMD.AU","SIG.AU","TLX.AU","CU6.AU","BK7113","BK7508","BK7511","SHL.AU","RHC.AU","BK7067","COH.AU","BK7096","MSB.AU","XJO.AU","BK7094","PME.AU","CSL.AU","FPH.AU","BK7007","BK7103"],"gpt_icon":0},{"id":"2502001298","title":"Which ASX 200 large-cap shares outperformed their peers in 2024?","url":"https://stock-news.laohu8.com/highlight/detail?id=2502001298","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502001298?lang=en_us&edition=fundamental","pubTime":"2025-01-10 11:03","pubTimestamp":1736478202,"startTime":"0","endTime":"0","summary":"In the highly uncertain economic environment of 2024, characterised by higher-for-longerinterest ratesandinflation, were ASX 200 large-cap shares a reliable safe haven for investors?The large caps are often less volatile in price movement and typically pay strong and reliable dividends.  This is because they are big blue-chip companies with greater capacity to weather economic upsets.  The large caps have a minimum market capitalisation of $10 billion.  At the time of writing, there are 49 large caps in the ASX 200. Let's take a look at which ASX 200 large-cap shares outperformed their peers in terms of share price growth last year.  Which ASX 200 large-cap shares outperformed in 2024?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/10/which-asx-200-large-cap-shares-outperformed-their-peers-in-2024/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["QAN.AU","BK7007","BK7016","FPH.AU","ALL.AU","CBA.AU","XJO.AU","GMG.AU","PME.AU","CPU.AU","RMD.AU","BK7510","XRO.AU","BK7155","BK7501","BK7001","WBC.AU","BK7099","IAG.AU","BK7511","BK7078","BK7064","BK7135","BK7033","JBH.AU","TNE.AU","BK7157","BK7094","BK7030","BXB.AU","BK7503","SUN.AU","BK7034"],"gpt_icon":1},{"id":"2501666962","title":"Healthy gains: 5 best ASX 200 healthcare shares of 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2501666962","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501666962?lang=en_us&edition=fundamental","pubTime":"2025-01-07 02:00","pubTimestamp":1736186400,"startTime":"0","endTime":"0","summary":"ASX 200 healthcareshares performed well in 2024, with theS&P/ASX 200 Health Care Index(ASX: XHJ) rising 6.01% and delivering a 12-month total return, including dividends, of 7.51%. However, the health","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/07/healthy-gains-5-best-asx-200-healthcare-shares-of-2024/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["PME.AU","BK7094","BK7103","BK7007","XJO.AU","BK7096","FPH.AU","TLX.AU","SIG.AU","BK7067","BK7501","CU6.AU"],"gpt_icon":0},{"id":"2491520630","title":"Here are the top 10 ASX 200 shares today","url":"https://stock-news.laohu8.com/highlight/detail?id=2491520630","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491520630?lang=en_us&edition=fundamental","pubTime":"2024-12-16 14:08","pubTimestamp":1734329312,"startTime":"0","endTime":"0","summary":"It was a fairly nasty start to the trading week for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares this Monday. After a rough week last week, investors clearly didn't get their mojo back over th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/12/16/here-are-the-top-10-asx-200-shares-today-553/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["SGR.AU","WGX.AU","BK7104","BK7034","SDR.AU","BK7051","XJO.AU","TCL.AU","BOQ.AU","TLX.AU","HLS.AU","BK7139","BK7509","BK7078","BK7124","BK7007","BK7016","IAG.AU","BK7090","BK7501","AOV.AU","FPH.AU","BK7506","BK7067"],"gpt_icon":0},{"id":"2491235966","title":"The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2491235966","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491235966?lang=en_us&edition=fundamental","pubTime":"2024-12-13 03:43","pubTimestamp":1734032634,"startTime":"0","endTime":"0","summary":"If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for?Typically, we'll want to notice a trend of growing return on capital employed  and alongside that, an expanding base of capital employed. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. Having said that, while the ROCE is currently high for Fisher & Paykel Healthcare , we aren't jumping out of our chairs because returns are decreasing.Return on Capital Employed = Earnings Before Interest and Tax  ÷ . In the above chart we have measured Fisher & Paykel Healthcare's prior ROCE against its prior performance, but the future is arguably more important. If you'd like, you can check out the forecasts from the analysts covering Fisher & Paykel Healthcare  for free.If you'd like to know about the risks facing Fisher & Paykel Healthcare, we've discovered 3 warning signs that you should be aware of.If you want to search ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/A2L05KoPhUOIMerRrV3ANw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b930d5a31599c93a126d42fec25c035a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/A2L05KoPhUOIMerRrV3ANw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b930d5a31599c93a126d42fec25c035a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/returns-capital-fisher-paykel-healthcare-194354660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["FPH","BK4137","EBIT","BK7007","BK7501","FPH.AU","HCSG","BK4193"],"gpt_icon":1},{"id":"2489017785","title":"4 key megatrends and a handful of ASX stock ideas to play them","url":"https://stock-news.laohu8.com/highlight/detail?id=2489017785","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489017785?lang=en_us&edition=fundamental","pubTime":"2024-12-05 11:30","pubTimestamp":1733369401,"startTime":"0","endTime":"0","summary":"Recently, I had the good fortune to moderate a panel discussion for the institutional investor sentiment research company MarketMeter.The panel, featuring prominent fund managers Jun Bei Liu of Tribeca, Hugh Giddy of IML, and Kirsty Mackay-Fisher of WaveStone Capital, provided insights into four key investment megatrends:. Below are some of the highlights. The full session can be watched using the media player at the top of this wire.The panel was held as part of MarketMeter's inaugural Insights Lunch, held on Tuesday 3 December 2024.Economic regime change: Inflation and growth in Australia. Giddy outlined the impact of inflation on Australia's economy. He described the global shift from free markets to interventionist policies, with governments relying on money printing and credit growth.Liu highlighted the resilience of growth stocks, which often outperform regardless of GDP trends. However, she acknowledged that Australia's economy has navigated challenges like high inflation and a ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/4-key-megatrends-and-a-handful-of-asx-stock-ideas-to-play-them","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/4-key-megatrends-and-a-handful-of-asx-stock-ideas-to-play-them","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7510","XKO.AU","BK7049","BK7501","COH.AU","BK7089","BK7117","LU1303367103.USD","MVF.AU","BK7007","SHL.AU","BK7511","TLS.AU","LU1815336091.USD","BK7070","BK7508","BK7094","XAO.AU","PME.AU","XJO.AU","LU2098885051.SGD","GMG.AU","BK7113","ABY.AU","BK4137","BK7155","RBA","FLT.AU","BK7017","BK7128","FPH.AU","MPL.AU","WOW.AU","LU0757428866.USD","BK7042","BK7040","ORI.AU","LGL.AU","BK7099","BK7124"],"gpt_icon":0},{"id":"2486836380","title":"Fisher & Paykel Healthcare Corp Ltd (FSPKF) (H1 2025) Earnings Call Highlights: Strong ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2486836380","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486836380?lang=en_us&edition=fundamental","pubTime":"2024-11-28 15:03","pubTimestamp":1732777410,"startTime":"0","endTime":"0","summary":"Operating Revenue: $951 million, up 18% from the prior period .Net Profit After Tax: $153 million, up 43% from the prior period .Hospital Product Group Revenue: $591 million, up 21% year on year.Homecare Operating Revenue: $359 million, up 14% from the first half last year .Gross Margin: 61.9%, up 141 basis points from the same period last year .Operating Margin: 22.9%, an increase of 394 basis points .Operating Cash Flow: $233 million, up 49% from the same period last year.Capital Expenditure: $55 million for the half, down from $275.5 million in the same period last year.Net Cash: $50 million as of September 30.Interim Dividend: $0.185 per share, a 3% increase from the previous year.GuruFocus has detected 11 Warning Signs with FSPKF.Fisher & Paykel Healthcare Corp Ltd  reported an 18% increase in operating revenue for the first half of the 2025 financial year, reaching $951 million.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/sE92g9eVcIPohjRGXYY.qA--~B/aD00NTt3PTE5MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/us.finance.gurufocus/8ca2c31174f7166ed92e2b7cf02a129a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/sE92g9eVcIPohjRGXYY.qA--~B/aD00NTt3PTE5MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/us.finance.gurufocus/8ca2c31174f7166ed92e2b7cf02a129a"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fisher-paykel-healthcare-corp-ltd-070330337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["FPH.AU","FSPKF"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":47,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FPH.AU\",params:#limit:5,,,undefined,":[{"date":"2024-12-05","symbol":"FPH.AU","amount":0.256944,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-12-06","name":"FISHER & PAYKEL HEALTHCARE C","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-06","currency":"NZD","dateTimestamp":1733317200000,"payDate":"2024-12-18"},{"date":"2024-06-26","symbol":"FPH.AU","amount":0.326389,"announcedDate":null,"type":"dividend","market":"AU","newRecordDate":"2024-06-27","defaultRemindTime":1719360000000,"name":"FISHER & PAYKEL HEALTHCARE C","recordDate":"2024-07-10","payableDate":"2024-06-27","currency":"NZD","dateTimestamp":1719324000000,"payDate":"2024-07-10"},{"date":"2023-12-05","symbol":"FPH.AU","amount":0.0317647,"announcedDate":"2023-11-29","type":"dividend","market":"AU","newRecordDate":"2023-12-06","defaultRemindTime":1701730800000,"name":"Fisher & Paykel Healthcare Corp","recordDate":"2023-12-18","payableDate":"2023-12-06","currency":"NZD","dateTimestamp":1701694800000,"payDate":"2023-12-18"},{"date":"2023-06-26","symbol":"FPH.AU","amount":0.0405882,"announcedDate":"2023-05-26","type":"dividend","market":"AU","newRecordDate":"2023-06-27","defaultRemindTime":1687737600000,"name":"Fisher & Paykel Healthcare Corp","recordDate":"2023-07-07","payableDate":"2023-06-27","currency":"NZD","dateTimestamp":1687701600000,"payDate":"2023-07-07"},{"market":"AU","date":"2022-12-08","symbol":"FPH.AU","amount":0.0308823,"defaultRemindTime":1670454000000,"name":"Fisher & Paykel Healthcare Corp","recordDate":"2022-12-21","payableDate":"2022-12-09","currency":"NZD","type":"dividend","dateTimestamp":1670418000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FPH.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-07-06","recordDate":"2020-07-07","paymentDate":"2020-07-17","value":0.0273594,"currency":"NZD"},{"executeDate":"2020-12-03","recordDate":"2020-12-04","paymentDate":"2020-12-16","value":0.16,"currency":"NZD"},{"executeDate":"2021-06-24","recordDate":"2021-06-25","paymentDate":"2021-07-07","value":0.0388235,"currency":"NZD"},{"executeDate":"2021-12-02","recordDate":"2021-12-03","paymentDate":"2021-12-15","value":0.03,"currency":"NZD"},{"executeDate":"2022-06-22","recordDate":"2022-06-23","paymentDate":"2022-07-06","value":0.0397058,"currency":"NZD"}]}}